Intermittent Theta-burst Stimulation for Mild Cognitive Impairment
NCT: NCT06608316 · COMPLETED
Brief Summary
The objectives of this study are to: 1. Evaluating the Impact of iTBS on Cognitive and Physical Functions: The investigators will investigate the efficacy of intermittent theta burst stimulation (iTBS) in patients with mild cognitive impairment (MCI), focusing on its effects on dual-task walking abilities, balance abilities, and cognitive function. 2. Comparing Clinical Efficacy Based on Stimulation Sites: The investigators will compare the clinical efficacy of iTBS targeting the left dorsolateral prefrontal cortex (DLPFC) versus bilateral DLPFC stimulation. This comparison aims to directly examine potential differences in therapeutic outcomes based on the site of stimulation. 3. Investigating Neurophysiological Mechanisms: The investigators plan to elucidate the neurophysiological mechanisms underlying the improvements in cognitive functions and dual-task walking abilities in MCI patients facilitated by iTBS. This will be achieved using fNIRS neuroimaging of brain activity.
Frequently Asked Questions
What is Intermittent Theta-burst Stimulation for Mild Cognitive Impairment?
Intermittent Theta-burst Stimulation for Mild Cognitive Impairment is a clinical trial registered under NCT06608316. Current status: COMPLETED.
What is the status of NCT06608316?
The current status of NCT06608316 (Intermittent Theta-burst Stimulation for Mild Cognitive Impairment) is: COMPLETED.
When did Intermittent Theta-burst Stimulation for Mild Cognitive Impairment start?
Intermittent Theta-burst Stimulation for Mild Cognitive Impairment started on 2024-11-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.